Scott Nash
Overview
Explore the profile of Scott Nash including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fujieda S, Pinto J, Jang D, Han J, Mims J, De Corso E, et al.
Am J Otolaryngol
. 2025 Jan;
46(2):104596.
PMID: 39889367
Purpose: The global Assessing long-teRm Outcomes in dupiluMAb (AROMA) registry study aims to characterize the long-term, real-world use of dupilumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). This...
2.
Lane A, Mullol J, Hopkins C, Fokkens W, Lee S, Msihid J, et al.
Curr Med Res Opin
. 2024 Dec;
41(1):53-59.
PMID: 39618256
Objective: Loss of sense of smell is a cardinal symptom of chronic rhinosinusitis with nasal polyps (CRSwNP) and significantly impacts health-related quality-of-life. Dupilumab significantly improved smell outcomes (loss of smell...
3.
Hara Y, Jha M, Huang J, Han Y, Langohr I, Gaglia G, et al.
Allergy
. 2024 Oct;
80(2):440-461.
PMID: 39418114
IL-4 and IL-13 have non-redundant effects in olfaction, with loss of smell in mice evoked only by intranasal administration of IL-4, but not IL-13. IL-4-evoked pathophysiological effects on olfaction is...
4.
Soler Z, Nash S, Lane A, Patel Z, Lee S, Fokkens W, et al.
Adv Ther
. 2024 Oct;
41(12):4384-4395.
PMID: 39382822
Reduced sense of smell is a common symptom in patients with chronic rhinosinusitis (CRS). Although it is often under-diagnosed by healthcare providers, reduced sense of smell can have a substantial...
5.
Bachert C, Khan A, Hopkins C, Han J, Fokkens W, Mannent L, et al.
Ann Allergy Asthma Immunol
. 2024 Sep;
134(1):61-69.e12.
PMID: 39343385
Background: Frequently reported outcomes of clinical trials in chronic rhinosinusitis with nasal polyps (CRSwNP) may have limited relatability for patients. Objective: To enhance the patient relatability of outcomes in dupilumab...
6.
Hopkins C, Han J, Fokkens W, Wagenmann M, Guyot P, Khan A, et al.
J Allergy Clin Immunol Pract
. 2024 Sep;
12(12):3393-3401.e15.
PMID: 39326524
Background: Dupilumab and mepolizumab have shown efficacy and safety in treating chronic rhinosinusitis with nasal polyps (CRSwNP). Objective: Without available results from head-to-head randomized control trials (RCTs) comparing dupilumab with...
7.
Soler Z, Patel Z, Mullol J, Mattos J, Nash S, Xia C, et al.
Am J Rhinol Allergy
. 2024 Sep;
39(1):6-12.
PMID: 39300794
Objective: To evaluate the association between smell loss and other aspects of disease, and evaluate dupilumab efficacy in patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) and moderate or...
8.
Bachert C, Khan A, Fokkens W, Hopkins C, Gevaert P, Han J, et al.
J Allergy Clin Immunol
. 2024 Aug;
154(6):1442-1449.
PMID: 39151476
Background: Responder analyses of SINUS phase 3 study data have shown clinically meaningful improvements across multiple outcomes of treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) with dupilumab. Objective: Our...
9.
Lugogo N, Heffler E, Plaza V, Hilberg O, Xia C, Nash S, et al.
J Asthma Allergy
. 2024 Jun;
17:551-556.
PMID: 38860029
No abstract available.
10.
Fokkens W, Bachert C, Hopkins C, Marglani O, Praestgaard A, Nash S, et al.
Clin Transl Immunology
. 2024 Jun;
13(6):e1511.
PMID: 38854740
Objectives: This analysis assessed disease characteristics and response to dupilumab treatment in male and female patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) (SINUS-52 study; NCT02898454). Methods: Patients received...